Allergy to topical corticosteroids in inflammatory bowel disease

Monk, B.E.; Skipper, D.
April 2003
Gut;Apr2003, Vol. 52 Issue 4, p597
Academic Journal
Describes a case of allergy to topical corticosteroids in a patient with inflammatory bowel disease. Clinical pathology; Failure of the IBD to respond to appropriate topical steroid therapy; Treatment with oral Asacol (mesalazine).


Related Articles

  • Taking a closer look at IBD. Egan, Laurence J.; Sandborn, William // Gut;Feb2014, Vol. 63 Issue 2, pe1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the aspects of inflammatory bowel diseases (IBD), pathogenesis of intestinal inflammation, and use of 5-aminosalicylic acid-based therapies and corticosteroids for the treatment of IBD.

  • Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. Grønbæk, H.; Thøgersen, T.; Frystyk, J.; Vilstrup, H.; Flyvbjerg, A.; Dahlerup, J.F. // American Journal of Gastroenterology;Mar2002, Vol. 97 Issue 3, p673 

    OBJECTIVES:Catabolism and growth impairment are well known complications of chronic inflammatory bowel disease (CIBD). This may be caused by disease activity itself and/or the medical treatment, which may lead to changes in the growth hormone and insulinlike growth factor I (IGF-I) axis....

  • Flare-up of ulcerative colitis after systemic corticosteroids: A strong case for Strongyloides. Shomron Ben-Horin; Barshack, Iris; Chowers, Yehuda; Mouallem, Meir // World Journal of Gastroenterology;7/21/2008, Vol. 14 Issue 27, p4413 

    Super-imposed infection with intestinal organisms can mimic a flare-up of underlying disease in patients with inflammatory bowel disease (IBD). We report a case of patient with long standing ulcerative colitis (UC), who presented with abdominal pain, diarrhea and low-grade fever after receiving...

  • Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study. Balzola, Federico; Bernstein, Charles; Ho, Gwo-Tzer; Russell, Richard K. // Inflammatory Bowel Disease Monitor;2011, Vol. 12 Issue 2, p77 

    The article presents a study which examines the rates of mammography and cervical screening in women with inflammatory bowel disease (IBD). The investigators compared the population controls using the University of Manitoba IBD Epidemiology Database and other population-based data sources in...

  • Corticosteroid Use in a Prospective, Community-Based Cohort of Newly Diagnosed Inflammatory Bowel Disease Patients. Shapiro, Jason; Hagin, Sarah; Shah, Samir; Bright, Renee; Law, Meaghan; Moniz, Heather; Giacalone, Julie; Jackvony, Taylor; Taleban, Sasha; Samad, Zahid; Merrick, Marjorie; Sands, Bruce; LeLeiko, Neal; Shapiro, Jason M; Hagin, Sarah E; Shah, Samir A; Sands, Bruce E; LeLeiko, Neal S // Digestive Diseases & Sciences;Jun2016, Vol. 61 Issue 6, p1635 

    Background: Systemic corticosteroids (CS) are a mainstay of treatment for patients with newly diagnosed inflammatory bowel disease (IBD). Previous population-based studies report CS exposure rates range from 39 to 75 % within the first year of diagnosis with surgical resection...

  • Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease. Ogata, Haruhiko; Hibi, Toshifumi // Current Pharmaceutical Design;May2003, Vol. 9 Issue 14, p1107 

    Although the pathogenesis of inflammatory bowel disease (IBD) remains elusive, it appears that there is chronic activation of the immune and inflammatory cascade in genetically susceptible individuals. Current disease management guidelines have therefore focused on the use of anti-inflammatory...

  • Something's Fishy--A Supplement for UC?  // Alternative Medicine Alert;Jan2006, Vol. 9 Issue 1, p10 

    Discusses research being done on nutritional supplement for ulcerative colitis (UC). Reference to study by D. L. Seidner et al, which appeared in the 2005 issue of the journal "Clinical Gastroenterology Hepatology"; Efficacy of a balanced oral supplement enriched with fish oil, soluble fiber,...

  • STRONGYLOIDES STERCORALIS INFESTATION IN A PATIENT WITH SEVERE ULCERATIVE COLITIS. Ghoshal, Uday C.; Alexender, George; Ghoshal, Ujjala; Tripathi, Shweta; Krishnani, Narendra // Indian Journal of Medical Sciences;Mar2006, Vol. 60 Issue 3, p106 

    Asymptomatic infestation with Strongyloides stercoralis, common in the tropics, may result in potentially fatal hyperinfection during treatment with immunosuppressive drugs used to treat patients with severe ulcerative colitis (UC). Hence, importance of early recognition and treatment of this...

  • FATAL STRONGYLOIDIASIS IN A PATIENT WITH ULCERATIVE COLITIS AFTER CORTICOSTEROID THERAPY. Leung, Vincent K. S.; Liew, C. T.; Sung, Joseph J. Y. // American Journal of Gastroenterology;Aug1997, Vol. 92 Issue 8, p1383 

    Presents a case report of a patient with strongyloidiasis and ulcerative colitis after corticosteroid therapy. Role of the suppression of cell-mediated immunity by corticosteroids in the development of hyperinfection; Effect of corticosteroids on intraintestinal larvae; Contribution of S....


Read the Article


Sign out of this library

Other Topics